BioSpace News Archive

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the National Cancer Institute (NCI) has selected the company’s testing laboratory in Phoenix, AZ to participate in the ComboMATCH clinical trials, one of the NCI-funded precision medicine initiatives.

Knowles Precision Devices, a division of Knowles Corporation, recently introduced the MD Series, a range of medical-grade capacitors for implantable designs.

Apnimed, Inc. announced the company will be participating in several investor conferences in September 2023.

Pliant Therapeutics, Inc. announced participation in the following September investor conferences.

Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) today announced that the Company will virtually present at the H.C. Wainwright 25th Annual Global Investment Conference, being held September 11-13, 2023.

Cabaletta Bio, Inc. announced that the Company will participate in four upcoming investor conferences in September:

PaxMedica, Inc. (Nasdaq: PXMD) today announced that it will present at the H.C. Wainwright 25th Annual Global Investment Conference, which is scheduled to take place September 11 – 13, 2023, in New York, NY.

eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulator inhibitors for the treatment of cancer, announced that the management team will participate in and host 1x1 meetings at the following upcoming investor conferences.

MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that Mark Doerr, Chief Executive Officer, will participate in H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023.

Vor Bio, a clinical-stage cell and genome engineering company, announced that it will participate in the following upcoming investor conferences.